Evidence map›Paper›PMID 33282025›Full record

ArticleCanadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC

The status of naloxone in community pharmacies across Canada.

Randy So, Yazid Al Hamarneh, Mark Barnes, Michael A Beazely, Michael Boivin, Julie Laroche, Harsit Patel, Aaron Sihota, Tim Smith, Ross T Tsuyuki

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The opioid crisis: Naloxone and pharmacists to the rescue.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC
    Article
  5. Observational
  6. An economic evaluation of community pharmacy-dispensed naloxone in Canada.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC
    Article
  7. Frequently asked questions about naloxone: Part 1.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Randy SoUniversity of Alberta (So, Al Harmarneh, Tsuyuki), Edmonton, Alberta.ORCID https://orcid.org/0000-0002-3012-5344
Yazid Al HamarnehUniversity of Alberta (So, Al Harmarneh, Tsuyuki), Edmonton, Alberta.ORCID https://orcid.org/0000-0003-3984-3542
Mark BarnesUniversity of Alberta (So, Al Harmarneh, Tsuyuki), Edmonton, Alberta.
Michael A BeazelyUniversity of Alberta (So, Al Harmarneh, Tsuyuki), Edmonton, Alberta.
Michael BoivinUniversity of Alberta (So, Al Harmarneh, Tsuyuki), Edmonton, Alberta.
Julie LarocheUniversity of Alberta (So, Al Harmarneh, Tsuyuki), Edmonton, Alberta.
Harsit PatelUniversity of Alberta (So, Al Harmarneh, Tsuyuki), Edmonton, Alberta.
Aaron SihotaUniversity of Alberta (So, Al Harmarneh, Tsuyuki), Edmonton, Alberta.
Tim SmithUniversity of Alberta (So, Al Harmarneh, Tsuyuki), Edmonton, Alberta.
Ross T TsuyukiUniversity of Alberta (So, Al Harmarneh, Tsuyuki), Edmonton, Alberta.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33282025
PMCPMC7689620

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.